Ketamine has been shown to decrease symptoms of anxious depression quickly. This decrease has
been shown to last for up to one month. MRI technology will be used before and after ketamine
for patients with depression to examine the extent to which certain brain areas predict
ketamine's antidepressant effects.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Brain & Behavior Research Foundation National Institutes of Health (NIH)